University of Lausanne

• Chén, Oliver Y.

  Lead investigator

• Ho, Ping-Chih

  Lead investigator

• Subramaniapillai, Sivaniya

  Lead investigator

• Neukomm, Lukas

  Lead investigator

• Place, Nicolas

  Lead investigator

• Tsartsalis, Stergios

  Lead investigator

• Jopp, Daniela

  Lead investigator

• Prudent, Michel

  Lead investigator

• Locatelli, Isabella

  Lead investigator

• Maurer, Jurgen

  Lead investigator

• Desdín Micó, Gabriela

  Lead investigator

• Nanchen, David

  Lead investigator

• Squair, Jordan

  Lead investigator

• Allali, Gilles

  Lead investigator

• Clair, Carole

  Lead investigator

• Chartoumpekis, Dionysios

  Lead investigator

• Allagnat, Florent

  Lead investigator

• Selby, Kevin

  Lead investigator

• Sivaniya SS Subramaniapillai

  Lead investigator

• Vietti Violi, Naïk

  Lead investigator

Sources: openalex.org

• The Effect of Olive Leaf Extract Supplementation on Training-induced Skeletal Muscle Functional and Molecular Adaptations in Healthy Volunteers

  Recruiting, 60 people, 27 Jul 2026

• NCT06191965

  Collaborator, Phase 2/3, Recruiting, 100 people, 5 Jan 2024

• NCT00689793

  Phase 4, Completed, 154 people, 4 Jun 2008

Sources: clinicaltrials.gov

• Swiss National Science Foundation

  Project funding, FLAME (Fair, Lightweight, Affordable, Multimodal, and Explainable) Machine Learning Methods for Predicting Alzheimer’s Disease Using Personalized and Adaptive Multimodal Biomarkers, 10006845, CHF 491.8k, 2026–2029, 1 Jan 2026

• Swiss National Science Foundation

  Bilateral programmes, Modulating Inflammaging via Microbiome-Regulated Signaling in Hepatocytes and Kupffer Cells, 238769, CHF 625k, 2026–2029, 1 Jan 2026

• Swiss National Science Foundation

  Ambizione, Diverse Brains: A Global, Inclusive Approach to Health Equity in Brain Aging, 232925, CHF 905.1k, 2025–2029, 1 Nov 2025

• Swiss National Science Foundation

  Project funding, Regulation of pro-degenerative nicotinamide mononucleotide in Drosophila neurons, 10004522, CHF 885.8k, 2025–2029, 1 Oct 2025

• Swiss National Science Foundation

  Project funding, Sex difference in the response to resistance exercise: a comprehensive neuro-muscular approach, 229960, CHF 339.2k, 2025–2029, 1 Aug 2025

• Swiss National Science Foundation

  Ambizione, A translational assessment of central nervous system innate immunity to identify how social support and oxytocin interact to protect against Alzheimer’s disease, 223414, CHF 960.6k, 2025–2029, 1 Jul 2025

• Swiss National Science Foundation

  Agora, Welcome to your future: Centenarians of Switzerland, 231097, CHF 199.6k, 2025–2026, 1 May 2025

• Swiss National Science Foundation

  Project funding, Determining the role of proteostasis dysfunction in premature aging of irradiated and thalassemic erythrocytes (PROTEAGE), 10003077, CHF 543.5k, 2025–2029, 1 May 2025

• Swiss National Science Foundation

  Project funding, Projecting life expectancies for real populations, 10002701, CHF 236k, 2025–2029, 1 Apr 2025

• Swiss National Science Foundation

  Research Infrastructure, Survey of Health, Ageing and Retirement in Europe - Switzerland - 2025-2028, 229645, CHF 3.6m, 2025–2028, 1 Jan 2025

• Swiss National Science Foundation

  Ambizione, Rejuvenating hematopoietic stem cells through partial in vivo reprogramming for improved functionality in aging and bone marrow failure syndromes, 223607, CHF 906.8k, 2024–2028, 1 Dec 2024

• Swiss National Science Foundation

  Project funding, Role of new lipid biomarkers in severe hypercholesterolemia, 10000959, CHF 480k, 2024–2028, 1 Nov 2024

• Swiss National Science Foundation

  Spark, An mRNA ‘vaccine’ for spinal cord regeneration, 228646, CHF 100k, 2024–2025, 1 Nov 2024

• Swiss National Science Foundation

  Project funding, Motoric Cognitive Risk syndrome and physical activity: A window into the biology and disability of predementia A multi-center longitudinal Swiss study, 214855, CHF 720k, 2024–2028, 1 Apr 2024

• Swiss National Science Foundation

  Project funding, Effects of sex and gender on cardiovascular risk factors and mental disorders in a middle-aged population-based cohort, 220190, CHF 1.1m, 2024–2027, 1 Jan 2024

• Swiss National Science Foundation

  Spark, Cell-free RNA as a biomarker of the complications and long-term outcomes of obesity, 220825, CHF 100k, 2023–2024, 1 Dec 2023

• Swiss National Science Foundation

  Project funding, Dietary intervention to protect against peripheral artery disease, 219997, CHF 840k, 2023–2027, 1 Oct 2023

• Swiss National Science Foundation

  Scientific Exchanges, Colorectal cancer screening research symposium, 220370, CHF 2.9k, 2023, 1 Aug 2023

• Swiss National Science Foundation

  SNSF Swiss Postdoctoral Fellowships, Sex and gender-related differences in cardiometabolic risk and brain aging: a longitudinal investigation, 217174, CHF 229.5k, 2023–2025, 1 Aug 2023

• Swiss National Science Foundation

  IICT - PPI Preparatory Grant, PRESENT CRC: PREcision ScrEeniNg randomized non-inferiority Trial for ColoRectal Cancer, 221695, CHF 5k, 2023, 1 Jul 2023

Sources: openalex.org